Approaching 25 million people have received their first vaccine dose in the UK. Millions more in Europe also. The grand reopening is coming.
One element of our research intensity that has come into its own during the pandemic has been our data science team. In a rapidly changing world, their work alongside that of our healthcare team has been critical in understanding and finding evidence on the economy and underlying trends. Real time data and our contracts with our companies were the only real way of monitoring our investments. Click to read article
